The global diagnostic biomarker market is valued at US$26 billion on a remuneration basis by the end of 2019 and is expected to be valued at US$87 billion by 2027, providing a 16% CAGR over the forecast period. Medical practice requires the accuracy and accuracy of diagnosing diseases and disorders to formulate personalized treatment. Diagnostic […]
